Pfizer’s full-year revenues grow 23%, top $100B
UniQure nabs another gene therapy for ALS
Inovio orders 2nd round of layoffs in 6 months after vaccine flops
AstraZeneca, Novo Nordisk and Sanofi score 340B-related appeals court win over HHS
*please scroll down for all the latest news*
